Tradjenta
Need help?
Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.
What Is Tradjenta?
Tradjenta, also known by its generic name linagliptin, is a prescription medication that is primarily used to treat type 2 diabetes mellitus. This medication belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Tradjenta works by inhibiting the DPP-4 enzyme, which in turn increases the levels of incretin hormones in the body. These hormones play a crucial role in regulating blood sugar levels by stimulating the release of insulin and reducing the production of glucose by the liver. By helping to control blood sugar levels, Tradjenta can assist in managing diabetes and preventing complications associated with high blood sugar, such as kidney problems, nerve damage, and vision issues. It's important to note that Tradjenta is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis. Additionally, it should be used as part of a comprehensive treatment plan that includes a proper diet, regular exercise, and other medications as prescribed by a healthcare professional. Like any medication, Tradjenta may cause side effects, including headache, upper respiratory tract infection, and low blood sugar (hypoglycemia). It's important to speak with a doctor about potential risks and benefits before starting this medication, as well as report any concerning side effects experienced while taking it.
How to use Tradjenta?
Tradjenta, also known by its generic name linagliptin, is a medication that is prescribed to treat type 2 diabetes. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. To use Tradjenta, it is important to follow the instructions provided by your healthcare provider. Typically, the medication is taken orally, once a day, with or without food. The dosage may vary depending on individual needs, so it's essential to follow your doctor's guidance. It's important to note that Tradjenta is not a substitute for a healthy lifestyle. It should be used in conjunction with proper diet, regular exercise, and other diabetes management strategies as prescribed by your healthcare provider. If you have any concerns or questions about the usage of Tradjenta, it is advisable to consult with your doctor or pharmacist for personalized advice. They will provide you with the necessary information regarding dosage, administration, and potential side effects to ensure safe and effective use of the medication.
There are several warnings and precautions associated with the use of Tradjenta (linagliptin) for the treatment of diabetes. It's important to be aware of these in order to ensure safe and effective use of the medication. Firstly, Tradjenta should not be used in individuals with a known hypersensitivity or allergy to linagliptin or any of its components. There have been rare cases of severe and disabling joint pain reported in patients taking linagliptin or other medications in the same class. Patients experiencing this symptom are advised to discontinue the medication and consult their healthcare provider. It is also important to inform your healthcare provider if you have a history of pancreatitis, as there have been reports of acute pancreatitis in patients taking linagliptin. Additionally, it’s essential to monitor for signs and symptoms of heart failure while taking Tradjenta. If any symptoms such as shortness of breath, rapid weight gain, or swelling occur, medical attention should be sought immediately. Since Tradjenta has not been extensively studied in individuals with kidney or liver problems, cautious use and close monitoring are advised in such cases. Lastly, it is crucial to be aware that Tradjenta is not a substitute for a healthy lifestyle and should be used in conjunction with proper diet and exercise to manage diabetes effectively. Regular monitoring of blood sugar levels is also recommended. As always, it is important to consult with your healthcare provider or pharmacist for specific warnings and precautions associated with your individual medical condition and any other medications you may be taking.
Before taking Tradjenta (linagliptin), it is important to be aware of certain warnings and precautions. Here are a few key considerations to keep in mind: 1. Allergy: Individuals with a known allergy or hypersensitivity to linagliptin or any of the inactive ingredients in Tradjenta should not take this medication. 2. Kidney function: Tradjenta is primarily eliminated through the kidneys. Therefore, individuals with impaired kidney function may require a dosage adjustment or alternative treatment options. Your healthcare provider will assess your kidney function before prescribing Tradjenta. 3. Pancreatitis: In rare cases, linagliptin and other medications of the same class have been associated with inflammation of the pancreas, known as pancreatitis. Contact your healthcare provider immediately if you experience persistent and severe abdominal pain, with or without vomiting, while taking Tradjenta. 4. Hypoglycemia: Tradjenta is not known to cause low blood sugar levels (hypoglycemia) on its own. However, if you are taking it in combination with other medications that can cause hypoglycemia, such as insulin or certain oral diabetes medications, it is important to monitor your blood sugar levels carefully. 5. Heart failure: Some individuals with a history of heart failure have experienced worsening symptoms while taking medications like linagliptin. If you have a history of heart failure or are at an increased risk, your healthcare provider will evaluate the potential benefits and risks of using Tradjenta. Always consult with a healthcare professional or your prescribing doctor for personalized advice and guidance regarding the use of Tradjenta, taking into consideration your specific medical history, current medications, and overall health status.
Tradjenta (linagliptin) is a prescription medication commonly used to treat diabetes by controlling blood sugar levels. While it is generally well-tolerated, it may have some potential side effects to be aware of. Some common side effects of Tradjenta may include headache, upper respiratory tract infection, stuffy or runny nose, sore throat, and back pain. These side effects are usually mild and temporary, resolving on their own without any medical intervention. In rare cases, more serious side effects may occur. These can include pancreatitis (inflammation of the pancreas), severe joint pain, allergic reactions such as rash or itching, and low blood sugar levels (hypoglycemia) when used in combination with other diabetes medications. It's important to consult with your doctor if you experience any unusual or severe side effects while taking Tradjenta. They can evaluate your specific situation and determine the best course of action. By closely monitoring your health and following their guidance, you can help ensure the safe and effective use of this medication.
The active ingredient in Tradjenta is linagliptin. Linagliptin is a medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. This drug works by increasing the levels of incretin hormones in the body. Incretin hormones help regulate blood sugar levels by stimulating the release of insulin from the pancreas and reducing the production of glucose by the liver. Apart from linagliptin, the other ingredients in Tradjenta include: 1. Microcrystalline cellulose: It is used as a filler in the tablet formulation. 2. Lactose monohydrate: This is a type of sugar that helps with the tablet's stability and aids in proper drug absorption. 3. Croscarmellose sodium: This ingredient acts as a disintegrant, allowing the tablet to dissolve quickly once ingested. 4. Magnesium stearate: It is a lubricant that helps in the tablet manufacturing process. These additional ingredients are known as excipients and are necessary for the formulation and proper functioning of the medication. It is important to note that individuals with known allergies or sensitivities to any of these ingredients should consult their healthcare provider before taking Tradjenta.
To ensure the effectiveness and safety of Tradjenta (linagliptin), proper storage is crucial. Here are some guidelines to follow: 1. Temperature: Store Tradjenta at room temperature, ideally between 68°F and 77°F (20°C and 25°C). 2. Moisture: Keep the medication in its original packaging and protect it from excessive moisture. Avoid storing it in the bathroom or any area with high humidity. 3. Light: Protect Tradjenta from direct sunlight and excessive light exposure. Store it in a dark place or keep it in a light-resistant container. 4. Accessibility: Store Tradjenta in a place that is out of reach of children and pets, ensuring that it is safely secured. 5. Proper packaging: Keep the medication in its original blister pack until you are ready to take it. This helps to protect it from external elements and maintain its integrity. 6. Check expiration date: Always check the expiration date before using Tradjenta. Do not use the medication if it has expired. Properly dispose of any expired medications according to local guidelines. Remember to follow any additional storage instructions provided by your healthcare provider or the medication's packaging. If you have any specific concerns or questions about storage, it is best to consult with your pharmacist or healthcare provider for further guidance.